|
ALG8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.193000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.199400E-01 |
| Normal-vs-Stage2 |
6.066600E-01 |
| Normal-vs-Stage3 |
1.421040E-01 |
| Normal-vs-Stage4 |
8.350000E-01 |
| Stage1-vs-Stage2 |
2.313800E-01 |
| Stage1-vs-Stage3 |
2.135200E-01 |
| Stage1-vs-Stage4 |
6.198400E-01 |
| Stage2-vs-Stage3 |
7.030400E-02 |
| Stage2-vs-Stage4 |
4.812400E-01 |
| Stage3-vs-Stage4 |
1.875220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.344200E-01 |
| Normal-vs-AfricanAmerican |
6.684400E-02 |
| Normal-vs-Asian |
4.109600E-01 |
| Caucasian-vs-AfricanAmerican |
1.165590E-01 |
| Caucasian-vs-Asian |
5.392200E-01 |
| AfricanAmerican-vs-Asian |
9.981200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.769000E-01 |
| Normal-vs-Female |
8.855800E-01 |
| Male-vs-Female |
1.372380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.129600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.168400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.792400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.821800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.027200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.373800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.148000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.188200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.378410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.754620E-01 |
| Normal-vs-Grade 2 |
6.472200E-01 |
| Normal-vs-Grade 3 |
2.748000E-01 |
| Normal-vs-Grade 4 |
5.656800E-01 |
| Grade 1-vs-Grade 2 |
2.379400E-01 |
| Grade 1-vs-Grade 3 |
5.350200E-01 |
| Grade 1-vs-Grade 4 |
4.498600E-01 |
| Grade 2-vs-Grade 3 |
3.855400E-01 |
| Grade 2-vs-Grade 4 |
7.909400E-01 |
| Grade 3-vs-Grade 4 |
7.315000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.713800E-01 |
| Normal-vs-ccB subtype |
3.563000E-01 |
| ccA subtype-vs-ccB subtype |
2.373600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.872800E-01 |
| Normal-vs-N1 |
7.966000E-01 |
| N0-vs-N1 |
6.865200E-01 |
|
|
